In 2007, the CIN started with 25 principal investigators as cluster applicants, as stipulated in the DFG call for bids. When the CIN cluster was approved further scientists from a range of institutions were incorporated, to make up the 48 'founding members' of the CIN. Since the beginning of 2014 the CIN has consisted of over 80 scientists in total. The membership process involves an application to the steering committee in which the candidate outlines his or her scientific profile and submits a list of publications. The committee's decision is based purely on the scientific excellence of each candidate.
Prof. Dr. Bernd Antkowiak
Organization: University Hospital Tübingen
Phone number: +49 (0)7071 29 81121
Department: Dept. of Anesthesiology and Intensive Care, Experimental Anesthesiology Section
Area: CIN Members
Scientific topic: GABA(A)-receptor-subtypes, anesthetics, cerebral cortex, spinal cord
Field of Research
Anesthetic agents in current clinical use display little molecular selectivity and therefore produce a large number of unwanted side effects. We hypothesize that essential components of anesthesia such as unconsciousness, amnesia and immobility can, in principle, be achieved by highly selective pharmacological interventions. Research into the recently discovered various subtypes of the GABA(A)-receptor is expected to translate into drugs with an improved side effect profile. Therefore it is a major aim of our group to elucidate how these subtypes modulate information processing in the cerebral cortex and spinal cord.
anaesthesia; cell culture (organotypic); molecular & cellular neurobiology; neuro-pharmacology; neuro-physiology
- Rudolph U, Antkowiak B (2004). Molecular and neuronal substrates for general anaesthetics. Nat Rev Neurosci. 5(9):709-20.
- Grasshoff C, Jurd R, Rudolph U, Antkowiak B (2007). Modulation of presynaptic beta3-containing GABA(A) receptors limits the immobilizing actions of GABAergic anesthetics. Mol Pharmacol. 72(3):780-7.
- Drexler B, Jurd R, Rudolph U, Antkowiak B (2009). Distinct actions of etomidate and propofol at beta3-containing gamma-aminobutyric acid type A receptors. Neuropharmacology. 57(4):446-55.